Gregory Bonfiglio, JD
Bonfiglio is the Founder and Managing Partner of Proteus LLC, an investment and advisory firm focused solely on regenerative medicine. Formed in 2006, Proteus provides fund management and consulting services to the regenerative medicine industry. Proteus works with regenerative medicine companies across all levels of development, from early stage entities to large pharma and biotech companies, as well as governmental organizations pursuing regenerative medicine initiatives.
He is the Chairman of the Board of the Centre for Commercialization of Regenerative Medicine in Toronto, Canada. Bonfiglio serves on the Board of Healios KK, one of the largest publicly traded regenerative medicine companies in Japan. In addition, he has served on the boards of several other regenerative medicine companies, including VistaGen Therapeutics (in vitro tools from hESCs); Advanced Cell Technologies (hESC therapeutics); California Stem Cell (hESC tools and therapeutics); and StemCyte, Inc. (cord blood storage and therapeutics).
Bonfiglio was an early investor in the field of stems cell and regenerative medicine, and he continues to be actively involved in the field. He is a frequent speaker at regenerative medicine conferences and is a member of the ISSCR, as well as serving on its advisory board, as well as its Finance Committee. He also is a member of the ISCT. In 2013, Bonfiglio was listed 14th among the Top 50 Stem Cell Influencers in the world.
He has more than 25 years’ experience working with technology companies. From 2000-05, Mr. Bonfiglio was a General Partner with Anthem Venture Partners – an early stage venture fund in California. While at Anthem, Mr. Bonfiglio led investments in both biotechnology and IT.
Prior to joining Anthem, he was a Partner with Morrison & Foerster, where he worked extensively with technology clients. Bonfiglio was an Adjunct Professor of Law at Stanford Law School from 1996-2000. He has been a Guest Lecturer at the Stanford Business School on the Commercialization of Regenerative Medicine Technologies. From 1995-2005, he was a regular Guest Lecturer at the UC Berkley Haas Business School in the Entrepreneurship Program.
Bonfiglio received his bachelor of arts degree in Mathematics (magna cum laude) from Michigan State University in 1975, and his J.D. (magna cum laude) from the University of Michigan Law School in 1981.